News Daily News FDA: Some Tainted Losartan Must Remain on US Market to Maintain Adequate Access for Patients L.A. McKeown March 21, 2019
News Daily News FDA Provides Update on Tainted ARB Investigation, With New Impurity Found Todd Neale March 04, 2019
News Daily News FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat Shelley Wood February 22, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2019 Caitlin E. Cox January 31, 2019
News Daily News More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities Shelley Wood December 10, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2018 Shelley Wood November 30, 2018
News Daily News FDA Warns of Stroke and Arterial Dissection Risk With MS Drug L.A. McKeown November 29, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2018 Caitlin E. Cox September 04, 2018
News Daily News Among African Americans in Need of LDL Lowering: Less Statin Use, More Distrust of Doctors Michael O'Riordan June 13, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2017 Shelley Wood October 29, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2017 Shelley Wood September 30, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2017 Shelley Wood June 01, 2017
News Daily News Alirocumab to Remain On Market While Companies Clash Over Patents Michael O'Riordan February 09, 2017
News Features Coalition of the Willing: PERTs Aim to Disentangle ‘Gordian Knot’ of Acute Pulmonary Embolism Todd Neale January 02, 2017
News Daily News Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes Michael O'Riordan August 12, 2016
News Daily News FDA: No More Chances for Embattled Coagulation Monitoring System Todd Neale July 13, 2016